LON:CREO - Creo Medical Group Stock Price, Price Target & More

GBX 122.50 +3.00 (+2.51 %)
(As of 04/25/2018 01:43 AM ET)
Previous CloseGBX 119.50
Today's RangeGBX 120 - GBX 124.25
52-Week RangeGBX 67.02 - GBX 130
Volume16,148 shs
Average Volume16,051 shs
Market Capitalization£91.76 million
P/E RatioN/A
Dividend YieldN/A

About Creo Medical Group (LON:CREO)

Creo Medical Limited develops and sells instruments for surgical endoscopy in the United Kingdom. The company is developing instruments for endoscopy through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. It offers Speedboat RS2 instrument for endoscopic submucosal dissection. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was founded in 2003 and is based in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Receive CREO News and Ratings via Email

Sign-up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-43.07%
Return on Assets-38.22%


Outstanding Shares80,710,000

How to Become a New Pot Stock Millionaire

Creo Medical Group (LON:CREO) Frequently Asked Questions

What is Creo Medical Group's stock symbol?

Creo Medical Group trades on the London Stock Exchange (LON) under the ticker symbol "CREO."

How were Creo Medical Group's earnings last quarter?

Creo Medical Group (LON:CREO) released its earnings results on Tuesday, March, 20th. The company reported ($5.00) earnings per share for the quarter. View Creo Medical Group's Earnings History.

Who are Creo Medical Group's key executives?

Creo Medical Group's management team includes the folowing people:
  • Mr. Craig Jonathan Gulliford, CEO & Director (Age 47)
  • Prof. Christopher Paul Hancock, Founder, CTO & Director (Age 50)
  • Mr. Steve Morris, Co-Founder and Chief Operating Officer
  • Mr. Richard John Rees ACA, CFO, Company Sec. & Director (Age 41)
  • Mr. Phil Hales, Sales & Marketing Director

Has Creo Medical Group been receiving favorable news coverage?

News headlines about CREO stock have been trending somewhat positive recently, Accern reports. The research firm rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Creo Medical Group earned a daily sentiment score of 0.20 on Accern's scale. They also assigned media headlines about the company an impact score of 44.92 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Creo Medical Group?

Shares of CREO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Creo Medical Group's stock price today?

One share of CREO stock can currently be purchased for approximately GBX 122.50.

How big of a company is Creo Medical Group?

Creo Medical Group has a market capitalization of £91.76 million.

How can I contact Creo Medical Group?

The company can be reached via phone at +44-1291-606005.

MarketBeat Community Rating for Creo Medical Group (CREO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Creo Medical Group and other stocks. Vote "Outperform" if you believe CREO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CREO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Creo Medical Group (LON:CREO) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/25/2016 forward)


Creo Medical Group (LON:CREO) Earnings History and Estimates Chart

Earnings by Quarter for Creo Medical Group (LON:CREO)

Creo Medical Group (LON CREO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/20/2018S1 2018GBX (5)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Creo Medical Group (LON:CREO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Creo Medical Group (LON CREO) Insider Trading and Institutional Ownership History

Insider Trading History for Creo Medical Group (LON:CREO)

Creo Medical Group (LON CREO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2018Steve MorrisInsiderBuy115,325GBX 68£78,421
12/21/2017Christopher Paul HancockInsiderBuy36,664GBX 69£25,298.16
4/4/2017Christopher Paul HancockInsiderBuy106,038GBX 82£86,951.16
(Data available from 1/1/2013 forward)


Creo Medical Group (LON CREO) News Headlines

Creo Medical Group (CREO) Announces Quarterly  Earnings ResultsCreo Medical Group (CREO) Announces Quarterly Earnings Results
www.americanbankingnews.com - March 20 at 7:12 AM
Steve Morris Buys 115,325 Shares of Creo Medical Group PLC (CREO) StockSteve Morris Buys 115,325 Shares of Creo Medical Group PLC (CREO) Stock
www.americanbankingnews.com - January 10 at 3:28 AM
Christopher Paul Hancock Purchases 36,664 Shares of Creo Medical Group PLC (CREO) StockChristopher Paul Hancock Purchases 36,664 Shares of Creo Medical Group PLC (CREO) Stock
www.americanbankingnews.com - December 22 at 5:26 AM

SEC Filings

Creo Medical Group (LON:CREO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.


Financials are not available for this stock.


Creo Medical Group (LON CREO) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.